Trastuzumab deruxtecan (Enhertu) is a treatment for breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations in certain patients. Trastuzumab deruxtecan may help people with cancer live longer and delay the progression of their disease.